Quantification of non-coding RNA target localization diversity and its application in cancers

Lixin Cheng1, Kwong-Sak Leung1

  • 1Department of Computer Science and Engineering, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.

Insights

We developed ncTALENT to measure non-coding RNA (ncRNA) target localization diversity. High diversity in ncRNA targets is linked to cancer and impacts clinical prognosis.

Area of Science:

  • Molecular Biology
  • Genomics
  • Bioinformatics

Background:

  • Subcellular localization is crucial for RNA and protein function.
  • Protein interaction localization diversity is studied, but ncRNA target protein localization diversity is not.
  • Understanding ncRNA target localization is vital, especially in cancer.

Purpose of the Study:

  • To develop a novel algorithm, ncTALENT, to quantify ncRNA target localization diversity.
  • To investigate the characteristics of target localization diversity in long non-coding RNAs (lncRNAs).
  • To explore the association between lncRNA target localization diversity and cancer.

Main Methods:

  • Developed the non-coding RNA target localization coefficient (ncTALENT) algorithm.
  • Utilized ncRNA-protein interaction and protein subcellular localization data.
  • Analyzed lncRNAs across different biotypes and in various cancer contexts.

Main Results:

  • ncTALENT quantifies how diversely ncRNA targets are distributed across subcellular locations.
  • Target localization diversity is a key characteristic of lncRNAs.
  • lncRNAs implicated in cancer, differentially expressed cancer lncRNAs, and those with multiple cancer targets exhibit higher diversity.
  • lncRNA target localization diversity is associated with clinical prognosis in gastric cancer.

Conclusions:

  • ncTALENT provides a novel metric for assessing ncRNA target localization diversity.
  • Target localization diversity is an intrinsic feature of lncRNAs with implications in cancer.
  • This diversity is linked to cancer development and patient outcomes, particularly in gastric cancer.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Local Anesthetics: Common Agents and Their Applications01:23

Local Anesthetics: Common Agents and Their Applications

Local anesthetics (LAs) are commonly used for various applications in medical and dental procedures. Some of the common agents used are cocaine, lidocaine, and bupivacaine.
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
992
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.7K
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
1.5K
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
788